ImtiazMaliikMD

Journal Articles

• Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: A randomized phase II study  
  Infante JR, Reid TR, Cohn AL, Edenfield WJ, Cescon TP, Hamm JT, Malik IA, et al, Cancer, 1/1/2013
• A phase I study of capecitabine, irinotecan, celecoxib & radiation as neoadjuvant therapy of patients with locally advanced rectal cancer  
  Malik I, Hussein F, Bush D, et al, Am J Clin Oncol, 1/1/2010
• A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced and metastatic adenocarcinoma of stomach or GE ...  
  Malik I, Bernal P, Byrd J, Cancer Investigation, 1/1/2010
• Reduction of neutropenia and febrile neutropenia in colorectal cancer patients receiving pegfilgrastim with every-2-week chemotherapy  
  Hecht JR, Pillai M, Gollard R, Heim W, Swan F, Patel R, Dreiling L, Mo M, Malik I, Clin Colorectal Cancer, 1/1/2010
• Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer  
  Hecht JR, Patnaik A, Berlin J, Venook A, Malik I, Tchekmedyian S, Navale L, Amado RG, Meropol NJ, Cancer, 1/1/2007
• Panitumumab with Irinotecan, Leucovorin, and 5-Fluorouracil (IFL or FOLFIRI) for First-Line Treatment of Metastatic Colorectal Cancer  
  Berlin J, Posey J, Tchekmedyian S, Hu E, Chan D, Malik I, et al, Clin Colorectal Cancer, 1/1/2007
• Panitumumab: a viewpoint by Imtiaz malik  
  Malik I, Drugs, 1/1/2006
• Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia  
  Boccia R, Malik IA, Raja V, Kahanic S, Liu R, Lillie T, Tomita D, Clowney B, Silberstein P, Oncologist, 1/1/2006
• Clinicopathological features of lung cancer and incidence of familial malignancy: A study of population in Karachi  
  Amanullah S, Zaidi SHM, Malik I, Pak J Chest Med, 1/1/2006
• Gallbladder cancer: current status  
  Malik I, Expert Opin Pharmacother, 1/1/2004
• Prospective evaluation of efficacy and toxicity of 5 FU and folinic acid (mayo clinic regimen) in patients with advanced cancer of the gallbladder  
  Malik IA, Aziz Z, Am J Clin Oncol, 1/1/2003
• Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder cancer  
  Malik IA, Aziz Z, Zaidi SH, Sethuraman G, Am J Clin Oncol, 1/1/2003
• Use of CAM results in delay in seeking medical advice for breast cancer  
  Malik IA, Sethuraman G, Eur J Epidemiol, 1/1/2003
• Gallbladder cancer in Pakistan: a prospective study of 233 cases  
  Malik I, J Gastroenterol Hepatol, 1/1/2003
• Contribution of mutations in BRCA1 and BRCA2 to breast and ovarian cancer in Pakistan  
  Liede A, Malik IA, Aziz Z, de la Rois P, Kwan E, Narod SA, Am J Hum Genet, 1/1/2002
• A prospective study of clinicopathological features of epithelial ovarian cancer in Pakistan  
  Malik I, J Pak Med Assoc, 1/1/2002
• Clinico-pathological features of breast cancer in Pakistan  
  Malik I, J Pak Med Assoc, 1/1/2002
• Comparison of meropenem with ceftazidime as monotherapy of cancer patients with febrile neutropenia  
  Malik I, Shaharyar, J Pak Med Assoc, 1/1/2002
• Clinicopathological features of Hodgkin's disease in Pakistani children and its management with chemotherapy alone  
  Malik I, Fatima N, Hussain M, Int J Ped Hem Oncol, 1/1/2001
• Influence of age and duration of symptoms on clinicopathological features and management of children with Hodgkin's disease  
  Malik I, Fatima N, Hussain M, Amanullah S, Qayyum A, Int J Ped Hem Oncol, 1/1/2001
• Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies  
  Malik IA, Hussain M, Yousuf H, J Infect, 1/1/2001
• Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer  
  Malik I, Jap J Clin Oncol, 1/1/2001
• Use of unconventional methods of therapy in Pakistan: comparison of cancer patients with those suffering from benign medical disorders  
  Malik I, Khan N, Khan M, Cancer Strategy, 1/1/2000
• Use of unconventional methods of therapy by the cancer patients  
  Malik IA, Khan NA, Khan W, Eur J Epidemiol, 1/1/2000
• An open label evaluation of topotecan in patients with relapsed or refractory epithelial ovarian cancer-single institution experience in a developing country  
  Malik I, Int J Gynecol Cancer, 1/1/2000
• Join now to see all

Books/Book Chapters

• The Non-Hodgkin's lymphoma 
  Chapter: Non-Hodgkin's lymphoma in developing countries. 
  Page 1031 - 1055Ahmad M, Malik IEditors: Magrath I.Arnold, London, United KingdomEdition 2nd,1997
• Communication with cancer patient: Information and truth. 
  Chapter: Communication with cancer patients. Experiences in Pakistan. 
  Page 300 - 308Malik I, Qureshi AFEditors: Surbone A, Zwitter M.Ann New York Acad Sci1997

Abstracts/Posters

• Pegfilgrastim in colorectal cancer (CRC) patients (pts) receiving every-two-week (Q2W) chemotherapy (CT): Long-term results from a phase 2, randomized, controlled study.
  Hecht JR, Pillai M, Gollard R, Dreiling L, Mo M, Malik I, Proc Am Soc Clin Oncol, 1/1/2009
• Panitumumab activity in metastatic colorectal cancer (mCRC) patients (pts) with low or negative tumor epidermal growth factor receptor (EGFr) levels: an interim analysis.
  Hecht JR, Mitchell E, Baranda J, Malik I, et al, ASCO GI Cancers Symposium, 1/1/2007
• Panitumumab activity in metastatic colorectal cancer (mCRC) patients (pts) with low or negative tumor epidermal growth factor receptor (EGFr) levels: an updated analysis.
  Mitchell E, Hecht JR, Baranda J, Malik I, et al, Proc Am Soc Clin Oncol, 1/1/2007
• Pegfilgrastim reduces the incidence of neutropenia in patients with locally advanced or metastatic colon cancer receiving chemotherapy administered every 2 weeks as fi...
  Malik I, Gollard R, Patel R, Tomita D, Dreiling L, Hecht, J, Support Care Cancer, 1/1/2007
• Panitumumab in combination with 5-flurouracil, leucovorin, and irinotecan (IFL) or FOLFIRI for first-line treatment of metastatic colorectal cancer (mCRC).
  Hecht J, Posey J, Tchekmedyian S, Hu, E, Chan D, Malik I, et al, ASCO Gastrointestinal Cancers Symposium, 1/1/2006
• Effectiveness of darbepoetin alpha administered every 3 weeks on clinical outcomes in patients with gastrointestinal cancer and chemotherapy induced anemia.
  Malik I, Kahanic S, Liu R, et al, ASCO Gastrointestinal Cancers Symposium, 1/1/2006
• Safety and efficacy of panitumumab monotherapy in patients with metastatic colorectal cancer.
  Malik I, Hecht JR, Patnaik A, et al, Proc Am Soc Clin Oncol, 1/1/2005
• ABX-EGF monotherapy in patients with metastatic colorectal cancer: an updated analysis.
  Hecht JR, Patnaik A, Malik I, et al, Proc Am Soc Clin Oncol, 1/1/2004
• Rates of consanguinity and BRCA mutations among breast and ovarian cancer patients in Pakistan.
  Aziz Z, Liede A, Malik I, et al, Proc Am Soc Clin Oncol, 1/1/2002
• Final results of a phase II trial of Taxotere (TXT) 100 or 75 mg/m2 as 2nd line chemotherapy (CT) in patients with metastatic breast cancer (MBC) with stratification a...
  Roth A, Ghilezan A, Lazarev A, Cufer T, Malik I, et al, Proc Am Soc Clin Oncol, 1/1/2000
• A phase II trial of taxotere (TXT) 100 or 75 mg/2 as 2nd line chemotherapy (CT) in patients (PTS) with metastatic breast cancer (MBC) with stratification according to ...
  Malik I, Lazarev A, Cufer T, Chernozemsky I, El-Ghamrawy K, Busidic Z, Doval D, Ghilezan N, Ionescu-Goga S, Quinaux E, Chirina N, Blanc C, Ann Oncol, 1/1/1999
• A prediction model to identify cancer patients with febrile neutropenia at low risk to develop a serious medical complication: Results from a multinational survey cond...
  Klastersky J, et al, Ann Oncol, 1/1/1998
• Evaluation of the effect of Topotecan on response and survival in patients with relapsed and refractory epithelial ovarian cancer.
  Malik I, Abidin ZU, Ann Oncol, 1/1/1998
• A prospective randomized trial of fluconazole versus Amphotericin-B as empirical anti-fungal therapy of neutropenic febrile patients.
  Malik I, Moid I, Aziz Z, Ann Oncol, 1/1/1994
• Predictive factors at admission of subsequent mortality in neutropenic febrile patients.
  Malik I, Moid I, Undre S, Munir T, Khan W, Ann Oncol, 1/1/1994
• Efficacy of ifosfamide and cisplatin in previously Lintreated patients with stage III-IV epithelial ovarian cancer and its correlation with peripheral blood lymphocyte...
  Aziz Z, Iqbal P, Sabih M, Malik I, Proc Am Soc Clin Oncol, 1/1/1994
• Immuno-histochemical analysis of estrogen receptors in patients with gallbladder cancer and it's correlation with clinico-pathological characteristics
  Malik I, Abbas Z, Qayyum A, Abid S, Proc Am Soc Clin Oncol, 1/1/1994
• Multicentre trial of single agent versus combination chemotherapy in metastatic breast cancer.
  Malik I, Aziz Z, Shahid M, Sarwar G, et al, Proc Am Soc Clin Oncol, 1/1/1993
• A randomized trial to evaluate the role of ofloxacin in the out-patient management of neutropenic febrile patients.
  Malik I, Aziz Z, Khan WA, Annals of Oncology, 1/1/1992
• Clinical features of non-Hodgkin's lymphoma in Pakistan.
  Aziz Z, Shafquat A, Malik I, Proc Am Soc Clin Oncol, 1/1/1992
• A randomized trial comparing oral ofloxacin alone with parenteral combination antibiotic therapy in patients with fever and neutropenia.
  Malik I, Abbas Z, Karim M, Proc Am Soc Clin Oncol, 1/1/1992
• Immunoproliferative small intestinal disease (IPSID) and small intestinal lymphoma.
  Malik I, Shafquat A, Shamsi Z, et al, Proc Am Soc Clin Oncol, 1/1/1992
• Nutritional factors in mammary carcinogenesis.
  Malik I, Sharif S, Badruddin S, Proc Am Soc Clin Oncol, 1/1/1992
• Clinical features of breast cancer in Pakistan.
  Malik I, Valimohammad A, Aziz Z, Malik F, et al, Proc Am Soc Clin Oncol, 1/1/1992
• Immuno-reactive forms of dihydrofolate reductase in human normal and cancer cells.
  Iqbal MP, Mehboobali N, Malik I, Ahmad M, Vohra I, Pakistan Journal of Zoology, 1/1/1991
• Join now to see all

Lectures

• Pegfilgrastim in colorectal cancer (CRC) patients (pts) receiving every-two-week (Q2W) chemotherapy (CT): Long-term results from a phase 2, randomized, controlled study. 
  Orlando, FL - 1/29/2009
• Effectiveness of darbepoetin alpha administered every 3 weeks on clinical outcomes in patients with gastrointestinal cancer and chemotherapy induced anemia. 
  San Francisco, CA - 1/18/2006
• Safety and efficacy of panitumumab monotherapy in patients with metastatic colorectal cancer. 
  Orlando, FL - 1/13/2005
• Clinical features and management of gallbladder cancer. 
  Karachi, Pakistan - 1/20/2002
• Rates of consanguinity and BRCA mutations among breast and ovarian cancer patients in Pakistan. 
  Orlando, FL - 1/18/2002
• Gemcitabine and cisplatin is highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. 
  Phoenix, AZ - 1/4/2002
• Update on infections in cancer patients. 
  Istanbul, Turkey - 1/3/2001
• Risk-stratification of febrile neutropenia: therapeutic implications. 
  Tata Memorial Hospital, Bombay, India - 1/26/1998
• Recent advances in management of febrile neutropenia. 
  Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan - 1/5/1998
• Clinicopathological features of epithelial ovarian cancer and management with Topotecan. 
  Cairo, Egypt - 1/4/1998
• Evaluation of the effect of Topotecan on response and survival in patients with relapsed and refractory epithelial ovarian cancer. 
  Athens, Greece - 1/1/1998
• Familial Breast Cancer. 
  Karachi, Pakistan - 1/1/1998
• What is new in the management of difficult wounds? 
  Karachi, Pakistan - 1/1/1998
• Recent advances and controversies in the management of febrile neutropenia. 
  Lahore, Pakistan - 1/1/1998
• Combining low cost with effective and practical therapy: A lesson from overseas 
  Toronto, Ontario, Canada - 1/28/1997
• Use of unconventional methods of therapy by the cancer patients. 
  Karachi, Pakistan - 1/1/1997
• A phase II study of growth factor supported intensive chemotherapy in poor-prognosis non-Hodgkin's lymphoma. 
  Penang, Malaysia - 1/17/1996
• A prospective randomized trial to evaluate the efficacy and tolerability of Tropisetron with or without dexamethasone against high-dose metoclopramide based anti-emeti... 
  Penang, Malaysia - 1/17/1996
• Out-patient Management of Febrile Neutropenia (Symposium) 
  Singapore - 1/1/1996
• Risk stratification in febrile neutropenia 
  Karachi, Pakistan - 1/1/1995
• Estrogen receptors in gallbladder cancer - a clinicopathological study. 
  Kuala Lumpur, Malaysia - 1/26/1994
• A prospective randomized trial of fluconazole versus amphotericin-B as empirical anti-fungal therapy of neutropenic febrile patients. 
  Lisbon, Portugal - 1/18/1994
• Predictive factors at admission of subsequent mortality in neutropenic febrile patients. 
  Lisbon, Portugal - 1/18/1994
• Clinico-pathological characteristics of non-Hodgkin's lymphomas and newer strategies to improve their management. 
  Medan, Indonesia - 1/1/1993
• A phase II study of ifosfamide and cisplatin in previously untreated patients with stage III-IV epithelial ovarian cancer. 
  Bangkok, Thailand - 1/1/1993
• Join now to see all